Skip to content

Phase 1 First-in-Human Study of JNJ-95566692 in Participants with NHLs

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-523297-16-00
Enrollment
13
Registered
2026-02-26
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Hodgkin Lymphoid Malignancies (NHLs)

Interventions

None listed

Sponsors

Janssen Cilag International
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 27, 2026